Streetbeat News

Assets

V

Visa (NYSE:V) has outperformed the market over the past 15 years, producing an average annual return of 19.7%. If an investor had bought $100 of V stock 15 years ago, it would be worth $1,548.82 today. The article emphasizes the impact of compounded returns on cash growth over time.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 7:00 pm

GE

A significant bearish stance has been taken on General Electric (NYSE:GE) by a large investor, as noticed by Benzinga's options scanner. The scanner spotted 16 uncommon options trades for GE, with the sentiment of these big-money traders being split between 31% bullish and 68% bearish. The whales have been targeting a price range from $100.0 to $125.0 for GE over the last 3 months. The price of GE is currently down -1.51% at $113.27.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:46 pm

GWW

W.W. Grainger (NYSE:GWW) has outperformed the market over the past 15 years, producing an average annual return of 14.56%. If an investor had bought $1000 of GWW stock 15 years ago, it would be worth $7,693.91 today. The company currently has a market capitalization of $34.26 billion.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:30 pm

AMGN

Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years, producing an average annual return of 10.27%. If an investor had bought $1000 of AMGN stock 15 years ago, it would be worth $4,209.06 today. The company currently has a market capitalization of $138.98 billion.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:30 pm

KR

A significant bearish stance has been taken on Kroger (NYSE:KR) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split, with 40% bullish and 60% bearish. The whales have been targeting a price range from $40.0 to $50.0 for Kroger over the last 3 months. Telsey Advisory Group has downgraded its action to Outperform with a price target of $55.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:16 pm

ABBV

A significant amount of unusual options activity has been detected for AbbVie (NYSE:ABBV), with a bearish stance being taken by a whale investor. Of the 16 strange trades detected, 43% were bullish and 56% were bearish. The trades included 2 puts amounting to $59,185 and 14 calls amounting to $680,506. The targeted price range for AbbVie over the last 3 months has been between $70.0 and $190.0. The current price of ABBV is up 1.78% at $151.92, with RSI indicators suggesting it may be approaching overbought.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:15 pm

FMX

Fomento Economico (NYSE:FMX) has outperformed the market over the past 20 years, producing an average annual return of 11.32%. If an investor had bought $100 of FMX stock 20 years ago, it would be worth $853.77 today. The company currently has a market capitalization of $192.62 billion.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:00 pm

FTNT

Over the past 10 years, Fortinet (NASDAQ:FTNT) has outperformed the market by 21.19% on an annualized basis, producing an average annual return of 31.29%. If an investor had bought $100 of FTNT stock 10 years ago, it would be worth $1,541.91 today.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:00 pm

ETHUSD

On Tuesday, 3,292.33 Ether (ETH) worth $5,266,484 was burned from Ethereum transactions. This follows the Ethereum blockchain's upgrade known as EIP-1159, which changed the fee model and burns a base fee from each transaction. Ethereum is currently issuing new Ether at a rate of 4% per year, expected to decrease to around 0.5-1% with the Ethereum 2.0 upgrade. The net annualized issuance rate for Ether yesterday was -1.75%.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 6:00 pm

NVO

A large bearish position has been taken on Novo Nordisk (NYSE:NVO), as observed in publicly available options history. The overall sentiment of these big-money traders is split between 31% bullish and 68% bearish. The whales have been targeting a price range from $160.0 to $210.0 for Novo Nordisk over the last 3 months. The price of NVO is currently down -1.82% at $193.16.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 5:46 pm